ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway

Sci. Signal., 9 February 2010
Vol. 3, Issue 108, p. ra9
DOI: 10.1126/scisignal.2000590

ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway

  1. Hsu-Ping Kuo1,2,
  2. Dung-Fang Lee1,2,
  3. Chun-Te Chen1,2,
  4. Mo Liu1,2,
  5. Chao-Kai Chou1,2,
  6. Hong-Jen Lee1,2,
  7. Yi Du1,2,
  8. Xiaoming Xie1,3,
  9. Yongkun Wei1,
  10. Weiya Xia1,
  11. Zhang Weihua4,
  12. Jer-Yen Yang1,2,
  13. Chia-Jui Yen1,
  14. Tzu-Hsuan Huang1,
  15. Minjia Tan5,
  16. Gang Xing6,
  17. Yingming Zhao6,*,
  18. Chien-Hsing Lin7,
  19. Shih-Feng Tsai7,
  20. Isaiah J. Fidler2,4, and
  21. Mien-Chie Hung1,2,8,9,
  1. 1Department of Molecular and Cellular Oncology, Unit 108, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
  2. 2Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, TX 77030, USA.
  3. 3Department of Breast Oncology, Sun Yat-Sen University Cancer Center, Guangzhou 510275, China.
  4. 4Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
  5. 5Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.
  6. 6Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  7. 7Division of Molecular and Genomic Medicine, National Health Research Institutes, Zhunan, Miaoli County 350, Taiwan.
  8. 8Center for Molecular Medicine and Graduate Institute of Cancer Biology, China Medical University and Hospital, Taichung 404, Taiwan.
  9. 9Asia University, Taichung 413, Taiwan.
  1. To whom correspondence should be addressed. E-mail: mhung{at}mdanderson.org
  • * Present address: Ben May Department for Cancer Research, The University of Chicago, Chicago, IL 60637, USA.

Abstract

Mammalian target of rapamycin (mTOR) regulates various cellular functions, including tumorigenesis, and is inhibited by the tuberous sclerosis 1 (TSC1)–TSC2 complex. Here, we demonstrate that arrest-defective protein 1 (ARD1) physically interacts with, acetylates, and stabilizes TSC2, thereby repressing mTOR activity. The inhibition of mTOR by ARD1 inhibits cell proliferation and increases autophagy, thereby inhibiting tumorigenicity. Correlation between ARD1 and TSC2 abundance was apparent in multiple tumor types. Moreover, evaluation of loss of heterozygosity at Xq28 revealed allelic loss in 31% of tested breast cancer cell lines and tumor samples. Together, our findings suggest that ARD1 functions as an inhibitor of the mTOR pathway and that dysregulation of the ARD1-TSC2-mTOR axis may contribute to cancer development.

Citation:

H.-P. Kuo, D.-F. Lee, C.-T. Chen, M. Liu, C.-K. Chou, H.-J. Lee, Y. Du, X. Xie, Y. Wei, W. Xia, Z. Weihua, J.-Y. Yang, C.-J. Yen, T.-H. Huang, M. Tan, G. Xing, Y. Zhao, C.-H. Lin, S.-F. Tsai, I. J. Fidler, and M.-C. Hung, ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway. Sci. Signal. 3, ra9 (2010).

Inhibition of STAT5a by Naa10p contributes to decreased breast cancer metastasis
Y. Zeng, L. Min, Y. Han, L. Meng, C. Liu, Y. Xie, B. Dong, L. Wang, B. Jiang, H. Xu et al.
Carcinogenesis 35, 2244-2253 (1 October 2014)

N-{alpha}-Acetyltransferase 10 protein inhibits apoptosis through RelA/p65-regulated MCL1 expression
H. Xu, B. Jiang, L. Meng, T. Ren, Y. Zeng, J. Wu, L. Qu, and C. Shou
Carcinogenesis 33, 1193-1202 (1 June 2012)

Human Protein N-terminal Acetyltransferase hNaa50p (hNAT5/hSAN) Follows Ordered Sequential Catalytic Mechanism: COMBINED KINETIC AND NMR STUDY
R. H. Evjenth, A. K. Brenner, P. R. Thompson, T. Arnesen, N. A. Froystein, and J. R. Lillehaug
J Biol Chem 287, 10081-10088 (23 March 2012)

Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis
Z. Wang, Z. Wang, J. Guo, Y. Li, J. H. Bavarva, C. Qian, M. C. Brahimi-Horn, D. Tan, and W. Liu
Proc. Natl. Acad. Sci. USA 109, 3053-3058 (21 February 2012)

mTOR Signaling, Function, Novel Inhibitors, and Therapeutic Targets
R. Watanabe, L. Wei, and J. Huang
JNM 52, 497-500 (1 April 2011)

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882